Zimmer Biomet Holdings, Inc. is reiterating financial guidance for current full-year 2024 . For the year, Reported Revenue Change is 4.5% - 5.5%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
108.5 USD | +0.14% | +0.62% | -10.82% |
06-20 | Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors | CI |
06-12 | Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.82% | 22.33B | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- ZBH Stock
- News Zimmer Biomet Holdings, Inc.
- Zimmer Biomet Holdings, Inc. Reiterates Financial Guidance for Current Full-Year 2024